產(chǎn)品說(shuō)明
腺苷受體激動(dòng)劑
該產(chǎn)品包含在以下化合物庫(kù)中:
質(zhì)量控制
化學(xué)性質(zhì)
CAS號(hào) | 40656-71-1 | ? | ? |
別名 | 6-Amino-2-chloropurine riboside,2-CADO,NSC 158900 |
分子式 | C11H13ClN4O4 | 分子量 | 300.7 |
溶解性 | Soluble in DMSO | 儲(chǔ)存條件 | Store at -20° |
?
實(shí)驗(yàn)操作
細(xì)胞實(shí)驗(yàn)[2]: |
細(xì)胞系 | |
溶解方法 | |
反應(yīng)時(shí)間 | |
應(yīng)用 | |
動(dòng)物實(shí)驗(yàn)[3]: |
動(dòng)物模型 | |
劑量 | |
注意事項(xiàng) | |
References: |
產(chǎn)品描述
2-chloro-3-Deazaadenosine, a stable analog of adenosine, is an agonist for adenosine receptors [1].
Adenosine receptors are members of G-protein-coupled receptors (GPCRs). Extracellular adenosine acts as a local modulator with a generally cytoprotective function in the body. Extracellular adenosine has been implicated in increasing the ratio of oxygen supply to demand, protecting against ischaemic damage by cell conditioning, triggering anti-inflammatory responses and the promotion of angiogenesis [2].
In vitro: The Ki values of 2-chloro-3-Deazaadenosine for A1, A2A, A2B, and A3 receptors were 0.3, 0.08, 25.5, and 1.9 μM, respectively [1]. 2-chloroadenosine (25 μM) increased activity of platelet adenylate cyclase to about 150–160% of the control value. Higher concentrations of 2-chloroadenosine showed less effect above 100 μM [3].
In vivo: In the rat with delayed ischaemic damage, Iterative focal injections of 2-chloroadenosine protected against selective hippocampal CA1 loss [4].
References:
[1] Linden J, Thai T, Figler H, et al.? Characterization of Human A2B Adenosine Receptors: Radioligand Binding, Western Blotting, and Coupling to Gqin Human Embryonic Kidney 293 Cells and HMC-1 Mast Cells[J]. Molecular Pharmacology, 1999, 56(4): 705-713.
[2] Jacobson K A, Gao Z G.? Adenosine receptors as therapeutic targets[J]. Nature Reviews Drug Discovery, 2006, 5(3): 247-264.
[3] Haslam R J, Lynham J A.? Activation and inhibition of blood platelet adenylate cyclase by adenosine or by 2-chloroadenosine[J]. Life Sciences, 1972, 11(23): 1143-1154.
[4] Evans M C, Swan J H, Meldrum B S.? An adenosine analogue, 2-chloroadenosine, protects against long term development of ischaemic cell loss in the rat hippocampus[J]. Neuroscience letters, 1987, 83(3): 287-292.
溫馨提示:不可用于臨床治療。